SCHEMBL12671174

SCHEMBL12671174

COBNCc1ccc(Nc2ncc3cc(C#C[Si](C)(C)C)ccc3n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 20/20 0.45
▸ RAF1 P04049 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13225903 0.83 BRAF (0.41) BRAFRAF1
SCHEMBL13574109 0.82 BRAF (0.48) BRAFRAF1
SCHEMBL13225905 0.82 BRAF (0.41) BRAFRAF1
SCHEMBL12671175 0.81 BRAF (0.49) BRAFRAF1
SCHEMBL12671534 0.75 CDK4 (0.39) BRAF
SCHEMBL1847410 0.70 BRAF (0.51) BRAF
SCHEMBL13225923 0.68 MAP4K1 (0.41) —
SCHEMBL12671538 0.67 BRAF (0.50) BRAF
SCHEMBL12671465 0.66 ALK (0.41) BRAF
SCHEMBL13225922 0.66 MAP4K1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079988-A9 QUINAZOLINES FOR PDK1 INHIBITION NOVARTIS AG (CH) 2011-05-12 — — WO disclosed
WO-2008079988-A2 QUINAZOLINES FOR PDK1 INHIBITION NOVARTIS AG (CH) 2008-07-03 — — WO disclosed
Send feedback